Promyelocytic leukemia protein: an atherosclerosis suppressor protein?

Cali B Corbett1, Amanda K St Paul1, Michael V Autieri1

  • 1Independence Blue Cross Cardiovascular Research Center Lemole Center for Integrated Lymphatic Research, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, U.S.A.

Insights

Vascular smooth muscle cells (VSMCs) are key in atherosclerosis. Research shows the tumor suppressor, promyelocytic leukemia protein (PML), regulates VSMC phenotype and inflammatory response, offering a new therapeutic target for this disease.

Area of Science:

  • Cardiovascular Biology
  • Cellular and Molecular Medicine
  • Atherosclerosis Research

Background:

  • Vascular smooth muscle cells (VSMCs) constitute up to 70% of atherosclerotic plaque.
  • VSMC migration, proliferation, and phenotype modulation are critical in atherosclerotic vascular disease development.
  • Novel therapeutic targets are needed to manage atherosclerosis.

Purpose of the Study:

  • To investigate the role of the tumor suppressor, promyelocytic leukemia protein (PML), in regulating VSMC phenotype.
  • To determine PML's involvement in VSMC response to inflammatory stimuli.
  • To explore PML as a potential therapeutic target for atherosclerosis.

Main Methods:

  • The study by Karle et al. examined the function of PML in VSMC.
  • Investigated the impact of PML on VSMC phenotype modulation.
  • Assessed VSMC responses to inflammatory stimuli in the context of PML expression.

Main Results:

  • PML plays a significant role in regulating VSMC phenotype.
  • PML influences VSMC response to inflammatory stimuli.
  • PML was previously unrecognized in atherosclerosis development.

Conclusions:

  • PML is an important regulator of VSMC phenotype and inflammatory response.
  • PML represents a novel therapeutic target for anti-atherosclerotic drug design.
  • Targeting PML may offer new strategies to combat atherosclerotic vascular disease.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
85
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
281
Inflammation01:38

Inflammation

Overview
56.9K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
877
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
124